These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 9827903)
61. Signal transduction via the CD38/NAD+ glycohydrolase. Kontani K; Kukimoto I; Kanda Y; Inoue S; Kishimoto H; Hoshino S; Nishina H; Takahashi K; Hazeki O; Katada T Adv Exp Med Biol; 1997; 419():421-30. PubMed ID: 9193684 [TBL] [Abstract][Full Text] [Related]
62. CD34+/CD105+ cells are enriched in primitive circulating progenitors residing in the G0 phase of the cell cycle and contain all bone marrow and cord blood CD34+/CD38low/- precursors. Pierelli L; Scambia G; Bonanno G; Rutella S; Puggioni P; Battaglia A; Mozzetti S; Marone M; Menichella G; Rumi C; Mancuso S; Leone G Br J Haematol; 2000 Mar; 108(3):610-20. PubMed ID: 10759721 [TBL] [Abstract][Full Text] [Related]
63. CD34+CD38-HLA-DR- correlate more closely than CD34+CD38- with engraftment post-PBSC transplantation. Drake M; Ranaghan EA; Alexander HD; Desai ZR; Morris TC Br J Haematol; 1999 Mar; 104(3):643-4. PubMed ID: 10086811 [No Abstract] [Full Text] [Related]
64. IL-3 increases production of B lymphoid progenitors from human CD34+CD38- cells. Crooks GM; Hao QL; Petersen D; Barsky LW; Bockstoce D J Immunol; 2000 Sep; 165(5):2382-9. PubMed ID: 10946261 [TBL] [Abstract][Full Text] [Related]
66. Ontogeny, distribution and function of CD38-expressing B lymphocytes in mice. Donís-Hernández FR; Parkhouse RM; Santos-Argumedo L Eur J Immunol; 2001 Apr; 31(4):1261-7. PubMed ID: 11298353 [TBL] [Abstract][Full Text] [Related]
67. Identification of human T-lymphoid progenitor cells in CD34+ CD38low and CD34+ CD38+ subsets of human cord blood and bone marrow cells using NOD-SCID fetal thymus organ cultures. Robin C; Bennaceur-Griscelli A; Louache F; Vainchenker W; Coulombel L Br J Haematol; 1999 Mar; 104(4):809-19. PubMed ID: 10192444 [TBL] [Abstract][Full Text] [Related]
68. Functional expression of Fas (CD95) in acute myeloid leukemia cells in the context of CD34 and CD38 expression: possible correlation with sensitivity to chemotherapy. Iijima N; Miyamura K; Itou T; Tanimoto M; Sobue R; Saito H Blood; 1997 Dec; 90(12):4901-9. PubMed ID: 9389707 [TBL] [Abstract][Full Text] [Related]
69. Characterization of a population of cells in the bone marrow that phenotypically mimics hematopoietic stem cells: resting stem cells or mystery population? Randall TD; Weissman IL Stem Cells; 1998; 16(1):38-48. PubMed ID: 9474746 [TBL] [Abstract][Full Text] [Related]
70. Enzyme properties of Aplysia ADP-ribosyl cyclase: comparison with NAD glycohydrolase of CD38 antigen. Inageda K; Takahashi K; Tokita K; Nishina H; Kanaho Y; Kukimoto I; Kontani K; Hoshino S; Katada T J Biochem; 1995 Jan; 117(1):125-31. PubMed ID: 7775378 [TBL] [Abstract][Full Text] [Related]
71. Induction of retinoic acid receptor-alpha by granulocyte macrophage colony-stimulating factor in human myeloid leukemia cell lines. Shimizu T; Takeda K Cancer Res; 2000 Aug; 60(16):4544-9. PubMed ID: 10969805 [TBL] [Abstract][Full Text] [Related]
72. Phenotypic and functional characterization of committed and primitive myeloid and lymphoid hematopoietic precursors in human fetal liver. Roy V; Miller JS; Verfaillie CM Exp Hematol; 1997 May; 25(5):387-94. PubMed ID: 9168060 [TBL] [Abstract][Full Text] [Related]
73. Retinoic acid is a negative regulator for the differentiation of cord blood-derived human mast cell progenitors. Kinoshita T; Koike K; Mwamtemi HH; Ito S; Ishida S; Nakazawa Y; Kurokawa Y; Sakashita K; Higuchi T; Takeuchi K; Sawai N; Shiohara M; Kamijo T; Kawa S; Yamashita T; Komiyama A Blood; 2000 May; 95(9):2821-8. PubMed ID: 10779427 [TBL] [Abstract][Full Text] [Related]
74. CD34-positive cells and their subpopulations characterized by flow cytometry analyses on the bone marrow of healthy allogenic donors. Carvalho JM; Souza MK; Buccheri V; Rubens CV; Kerbauy J; Oliveira JS Sao Paulo Med J; 2009 Jan; 127(1):12-8. PubMed ID: 19466289 [TBL] [Abstract][Full Text] [Related]
75. Down-regulation of bcl-2 in AML blasts by all-trans retinoic acid and its relationship to CD34 antigen expression. Bradbury DA; Aldington S; Zhu YM; Russell NH Br J Haematol; 1996 Sep; 94(4):671-5. PubMed ID: 8826891 [TBL] [Abstract][Full Text] [Related]
76. Clonal chromosomal abnormalities in the stem cell compartment of patients with acute myeloid leukemia in morphological complete remission. Feuring-Buske M; Haase D; Buske C; Hiddemann W; Wörmann B Leukemia; 1999 Mar; 13(3):386-92. PubMed ID: 10086729 [TBL] [Abstract][Full Text] [Related]
77. Post-translational modification of CD38 protein into a high molecular weight form alters its catalytic properties. Umar S; Malavasi F; Mehta K J Biol Chem; 1996 Jul; 271(27):15922-7. PubMed ID: 8663150 [TBL] [Abstract][Full Text] [Related]
78. Cytogenetically aberrant cells are present in the CD34+CD33-38-19- marrow compartment in children with acute lymphoblastic leukemia. Quijano CA; Moore D; Arthur D; Feusner J; Winter SS; Pallavicini MG Leukemia; 1997 Sep; 11(9):1508-15. PubMed ID: 9305606 [TBL] [Abstract][Full Text] [Related]
79. ATRA-induced HL-60 myeloid leukemia cell differentiation depends on the CD38 cytosolic tail needed for membrane localization, but CD38 enzymatic activity is unnecessary. Congleton J; Jiang H; Malavasi F; Lin H; Yen A Exp Cell Res; 2011 Apr; 317(7):910-9. PubMed ID: 21156171 [TBL] [Abstract][Full Text] [Related]
80. Molecular mechanism of human CD38 gene expression by retinoic acid. Identification of retinoic acid response element in the first intron. Kishimoto H; Hoshino S; Ohori M; Kontani K; Nishina H; Suzawa M; Kato S; Katada T J Biol Chem; 1998 Jun; 273(25):15429-34. PubMed ID: 9624127 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]